Macquarie Group Ltd. boosted its stake in shares of Natera, Inc. (NASDAQ:NTRA) by 25.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,336,993 shares of the medical research company’s stock after purchasing an additional 275,113 shares during the quarter. Macquarie Group Ltd. owned about 2.51% of Natera worth $17,234,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in NTRA. American International Group Inc. boosted its position in Natera by 7.1% during the first quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock worth $142,000 after purchasing an additional 1,068 shares during the period. Alliancebernstein L.P. boosted its position in Natera by 5.6% during the first quarter. Alliancebernstein L.P. now owns 26,600 shares of the medical research company’s stock worth $236,000 after purchasing an additional 1,400 shares during the period. TIAA CREF Investment Management LLC boosted its position in Natera by 14.3% during the first quarter. TIAA CREF Investment Management LLC now owns 93,901 shares of the medical research company’s stock worth $833,000 after purchasing an additional 11,743 shares during the period. Vanguard Group Inc. boosted its position in Natera by 4.4% during the first quarter. Vanguard Group Inc. now owns 2,007,708 shares of the medical research company’s stock worth $17,808,000 after purchasing an additional 84,144 shares during the period. Finally, Geode Capital Management LLC boosted its position in Natera by 4.8% during the first quarter. Geode Capital Management LLC now owns 235,287 shares of the medical research company’s stock worth $2,086,000 after purchasing an additional 10,813 shares during the period. 60.79% of the stock is owned by hedge funds and other institutional investors.

Shares of Natera, Inc. (NASDAQ:NTRA) opened at $9.57 on Monday. Natera, Inc. has a 12-month low of $7.35 and a 12-month high of $14.76. The company has a debt-to-equity ratio of 2.43, a quick ratio of 1.75 and a current ratio of 1.85.

Natera (NASDAQ:NTRA) last posted its quarterly earnings data on Wednesday, November 8th. The medical research company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.04). The business had revenue of $56.66 million during the quarter, compared to the consensus estimate of $55.31 million. Natera had a negative net margin of 62.34% and a negative return on equity of 197.09%. The firm’s revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.50) earnings per share. analysts anticipate that Natera, Inc. will post -2.15 EPS for the current fiscal year.

A number of brokerages have issued reports on NTRA. Zacks Investment Research raised Natera from a “sell” rating to a “buy” rating and set a $9.25 target price for the company in a research report on Thursday, August 10th. ValuEngine raised Natera from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 10th. Morgan Stanley reduced their price objective on Natera from $18.00 to $13.00 and set an “overweight” rating for the company in a research report on Monday, August 7th. Cowen Inc reissued a “buy” rating and issued a $14.00 price objective on shares of Natera in a research report on Friday, September 1st. Finally, Robert W. Baird reissued a “buy” rating on shares of Natera in a research report on Tuesday, October 24th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $15.00.

In related news, insider Jonathan Sheena sold 120,000 shares of the company’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $12.54, for a total value of $1,504,800.00. Following the completion of the transaction, the insider now directly owns 533,208 shares in the company, valued at $6,686,428.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 12.57% of the company’s stock.

WARNING: “Natera, Inc. (NTRA) Holdings Raised by Macquarie Group Ltd.” was first posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.dailypolitical.com/2017/11/27/natera-inc-ntra-holdings-raised-by-macquarie-group-ltd.html.

About Natera

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.